|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES | |||
| Net income | |||
| Adjustments to reconcile net income to operating cash flows: | |||
| Depreciation and amortization | |||
| Deferred income taxes | |||
| Equity in income of investees, net of dividends | |||
| Share-based compensation | |||
| Impairment charges - Long-lived assets | |||
| Foreign currency remeasurement and transaction exposure | |||
| Changes in current assets and liabilities: | |||
| Trade and other receivables | |||
| Related party receivables | |||
| Inventories | |||
| Prepaid expenses and other current assets | |||
| Accounts payable | |||
| Related party payables | |||
| Other accrued expenses | |||
| Changes in other liabilities | |||
| Other, net | |||
| Net cash provided by operating activities | |||
| CASH USED IN INVESTING ACTIVITIES | |||
| Capital expenditures | |||
| Net cash used in investing activities | |||
| CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES | |||
| Long-term debt proceeds | |||
| Payments on long-term debt | |||
| Repurchases of Common stock | |||
| Dividends paid | |||
| Net transfers to Parent | |||
| Other, net | |||
| Net cash (used in) provided by financing activities | |||
| Effect of exchange rate changes on cash and cash equivalents | |||
| Net increase in cash and cash equivalents | |||
| Cash and cash equivalents at beginning of period | |||
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | |||
| SUPPLEMENTAL CASH FLOW INFORMATION: | |||
| Non-cash investing and financing activities: | |||
| Non-cash settlements with Parent | |||
| Non-cash Capital expenditures |
Loading...
